Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 25, 2012
Challenges in drug and biomarker co-developmentSheila E Taube, Tracy LivelyThe Lancet. Oncology|April 4, 2014
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working groupJacqueline Anne Hall, Roberto Salgado, Tracy Lively, et al.Nature Reviews. Drug Discovery|November 25, 2017
Steps forward for cancer precision medicineRoberto Salgado, Helen Moore, John W M Martens, et al.European Journal of Cancer (Oxford, England : 1990)|September 3, 2017
Societal challenges of precision medicine: Bringing order to chaosRoberto Salgado, Helen Moore, John W M Martens, et al.European Journal of Cancer (Oxford, England : 1990)|May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncologyRoberto Salgado, David B Solit, David L Rimm, et al.Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.JCO Precision Oncology|February 9, 2022
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United StatesAndrew N Freedman, Carrie N Klabunde, Kristine Wiant, et al.NEJM Evidence|July 23, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and SurvivalJoseph A Sparano, Michael Crager, Robert J Gray, et al.JAMA Oncology|October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical TrialJoseph A Sparano, Robert J Gray, Della F Makower, et al.Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.Pageof 2